Skip to main content

Context Therapeutics Inc.

CNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001842952

No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Context Therapeutics Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
42
+9 vs. Q2 2024
Shares held
56.7M
+499.8K (+0.9%) vs. Q2 2024
Total value
$111.2M
−$1.46M (−1.3%) vs. Q2 2024
New holders
15
6 more added
Sold out
6
10 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 42 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 19 institutionsQ1 2022: 16 institutionsQ2 2022: 20 institutionsQ3 2022: 24 institutionsQ4 2022: 24 institutionsQ1 2023: 22 institutionsQ2 2023: 22 institutionsQ3 2023: 23 institutionsQ4 2023: 24 institutionsQ1 2024: 25 institutionsQ2 2024: 34 institutionsQ3 2024: 42 institutionsQ4 2024: 52 institutionsQ1 2025: 42 institutionsQ2 2025: 39 institutionsQ3 2025: 37 institutionsQ4 2025: 43 institutionsQ1 2026: 60 institutionsQ2 2026: 79 institutions
Value heldQ3 2024: $111.2M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $9.44MQ1 2022: $6.30MQ2 2022: $6.32MQ3 2022: $4.59MQ4 2022: $2.55MQ1 2023: $722.6KQ2 2023: $3.58MQ3 2023: $3.89MQ4 2023: $4.02MQ1 2024: $5.43MQ2 2024: $114.3MQ3 2024: $111.2MQ4 2024: $76.4MQ1 2025: $43.7MQ2 2025: $45.0MQ3 2025: $66.8MQ4 2025: $96.0MQ1 2026: $194.6MQ2 2026: $34.8M
Institutions holding CNTX and their total value by quarter
QuarterHoldersValue
Q2 202679$34.8M
Q1 202660$194.6M
Q4 202543$96.0M
Q3 202537$66.8M
Q2 202539$45.0M
Q1 202542$43.7M
Q4 202452$76.4M
Q3 202442$111.2M
Q2 202434$114.3M
Q1 202425$5.43M
Q4 202324$4.02M
Q3 202323$3.89M
Q2 202322$3.58M
Q1 202322$722.6K
Q4 202224$2.55M
Q3 202224$4.59M
Q2 202220$6.32M
Q1 202216$6.30M
Q4 202119$9.44M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q2 2024.

Institutions holding CNTX in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Deep Track Capital, LP7,419,355$14.5M0.46%00.0%Unchanged
Nextech Invest AG7,419,355$14.5M2.04%00.0%Unchanged
Avidity Partners Management LP7,417,155$14.5M0.74%−2,2000.0%Reduced
Great Point Partners LLC6,934,982$13.6M4.10%−484,373−6.5%Reduced
Blue Owl Capital Holdings LP5,411,290$10.6M2.06%+250,000+4.8%Added
Vanguard Group Inc3,744,961$7.34M0.00%−757,237−16.8%Reduced
Blackstone Group Inc.2,440,330$4.78M0.02%+601,621+32.7%Added
Nantahala Capital Management, LLC1,935,484$3.79M0.32%00.0%Unchanged
Franklin Resources Inc1,853,988$3.69M0.00%+1,853,988New
Ally Bridge Group (NY) LLC1,757,524$3.44M1.84%−128,708−6.8%Reduced
Alyeska Investment Group, L.P.1,663,655$3.26M0.02%−271,829−14.0%Reduced
Woodline Partners LP1,360,682$2.67M0.02%+1,360,682New
Sio Capital Management, LLC1,328,352$2.60M1.17%00.0%Unchanged
Affinity Asset Advisors, LLC1,321,153$2.59M0.40%−297,987−18.4%Reduced
Velan Capital Investment Management LP1,290,323$2.53M2.75%00.0%Unchanged
BlackRock, Inc.848,970$1.66M0.00%+848,970New
Geode Capital Management, LLC575,899$1.13M0.00%−42,275−6.8%Reduced
ADAR1 Capital Management, LLC373,835$732.7K0.12%−271,326−42.1%Reduced
UBS Oconnor LLC308,758$605.2K0.02%+15,000+5.1%Added
Northern Trust Corp172,511$338.1K0.00%−1,986−1.1%Reduced
Millennium Management LLC143,883$282.0K0.00%+143,883New
HighTower Advisors, LLC125,852$247.0K0.00%00.0%Unchanged
State Street Corp111,907$219.3K0.00%+19,800+21.5%Added
Walleye Capital LLC109,655$214.9K0.00%+1,279+1.2%Added
Mill Creek Capital Advisors, LLC104,631$205.1K0.00%00.0%Unchanged
Qube Research & Technologies Ltd103,405$202.7K0.00%+103,405New
Renaissance Technologies LLC66,000$129.4K0.00%+800+1.2%Added
Susquehanna International Group, LLP54,211$106.3K0.00%+54,211New
Aster Capital Management (DIFC) Ltd52,792$103.5K0.02%+52,792New
Y-Intercept (Hong Kong) Ltd45,635$89.4K0.01%+45,635New
Citigroup Inc44,779$87.8K0.00%+44,779New
Jefferies Financial Group Inc.43,200$84.7K0.00%+43,200New
Clear Harbor Asset Management, LLC36,000$70.6K0.01%00.0%Unchanged
Caxton Corp18,403$36.1K0.15%00.0%Unchanged
Two Sigma Investments, LP13,844$27.1K0.00%00.0%Unchanged
Bank of America Corp10,192$20.0K0.00%−584−5.4%Reduced
Cerity Partners LLC10,000$19.6K0.00%+10,000New
Tower Research Capital LLC (TRC)7,155$14.0K0.00%+7,155New
UBS Group AG1,717$3.37K0.00%+1,717New
Advisor Group Holdings, Inc.500$9800.00%00.0%Unchanged
AdvisorNet Financial, Inc200$3920.00%+200New
JPMorgan Chase & Co173$3390.00%+173New
Driehaus Capital Management LLC0$00.00%−2,258,065−100.0%Sold out
Altium Capital Management LP0$00.00%−360,001−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−41,469−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−24,750−100.0%Sold out
Verition Fund Management LLC0$00.00%−16,294−100.0%Sold out
Federation des caisses Desjardins du Quebec0$00.00%−400−100.0%Sold out
BlackRock Inc.––––Not filed